Document Detail


Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome.
MedLine Citation:
PMID:  21346062     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: In preclinical reports, restriction of dietary methionine intake was shown to enhance metabolic flexibility, improve lipid profiles, and reduce fat deposition. The present report is the outcome of a "proof of concept" study to evaluate the efficacy of dietary methionine restriction (MR) in humans with metabolic syndrome.
METHODS: Twenty-six obese subjects (six male and 20 female) meeting criteria for metabolic syndrome were randomized to a diet restricted to 2 mg methionine/kg body weight per day and were provided capsules containing either placebo (n = 12) or 33 mg methionine/kg body weight per day (n = 14). Energy expenditure, body composition, insulin sensitivity, and biomarkers of metabolic syndrome were measured before and after 16 wk on the respective diets.
RESULTS: Insulin sensitivity and biomarkers of metabolic syndrome improved comparably in both dietary groups. Rates of energy expenditure were unaffected by the diets, but dietary MR produced a significant increase in fat oxidation (MR, 12.1 ± 6.0% increase; control, 8.1 ± 3.3% decrease) and reduction in intrahepatic lipid content (MR liver/spleen attenuation ratio, 8.1 ± 3.3% increase; control ratio, 2.2 ± 2.1% increase) that was independent of the comparable reduction in weight and adiposity that occurred in both groups.
CONCLUSIONS: Sixteen weeks of dietary MR in subjects with metabolic syndrome produced a shift in fuel oxidation that was independent of the weight loss, decreased adiposity, and improved insulin sensitivity that was common to both diets.
Authors:
Eric P Plaisance; Frank L Greenway; Anik Boudreau; Kasey L Hill; William D Johnson; Rozlyn A Krajcik; Carmen E Perrone; Norman Orentreich; William T Cefalu; Thomas W Gettys
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-02-23
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  96     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-05-05     Completed Date:  2011-06-30     Revised Date:  2012-05-01    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  E836-40     Citation Subset:  AIM; IM    
Affiliation:
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA.
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00640757
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adipose Tissue / drug effects,  metabolism*
Biological Markers / blood
Body Composition / physiology
Cohort Studies
Cystine / blood
Diet*
Dietary Fats / metabolism
Double-Blind Method
Energy Metabolism / physiology
Fats / metabolism*
Female
Glucose / metabolism
Humans
Insulin Resistance / physiology
Kinetics
Liver / metabolism
Male
Metabolic Syndrome X / metabolism*
Methionine / blood,  pharmacology*
Middle Aged
Obesity / metabolism*
Oxidation-Reduction
Waist Circumference / physiology
Grant Support
ID/Acronym/Agency:
1P30 DK072476/DK/NIDDK NIH HHS; P20-RR021945/RR/NCRR NIH HHS; P50AT002776-01/AT/NCCAM NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Dietary Fats; 0/Fats; 50-99-7/Glucose; 56-89-3/Cystine; 63-68-3/Methionine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Carbohydrate metabolism and the skeleton: picking a bone with the beta-cell.
Next Document:  Absence of circadian rhythms of gonadotropin secretion in women.